Literature DB >> 3885997

Further studies of the reasons for the lack of alveolar infection during influenza in ferrets.

C Sweet, R A Bird, A J Howie, H A Overton, D M Coates, H Smith.   

Abstract

Intratracheal inoculation of influenza virus in the ferret was followed by a more severe airway infection than that produced by nasal infection and was mainly bronchiolar rather than bronchial. Also, virus isolation from the alveolar zone of the lung together with immunofluorescence and immunoperoxidase techniques showed that some virus reached the alveoli. Nevertheless, there was no subsequent alveolitis suggesting the existence of a clearance phenomenon. Alveolar macrophages were shown to have phagocytosed virus in vivo and phagocytosis studies in vitro showed that two mechanisms could operate to eradicate the virus. First, a rapid destruction of virus and second an abortive cycle of replication which produced virus antigen but not infectious virus. Experiments with large doses of virus indicated that after intranasal inoculation little virus reached the alveoli so it would probably be quickly cleared by the macrophages.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3885997      PMCID: PMC2041048     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  10 in total

Review 1.  Deposition of aerosol in the respiratory tract.

Authors:  J D Brain; P A Valberg
Journal:  Am Rev Respir Dis       Date:  1979-12

2.  Studies of the basis of localization of influenza virus in ferret organ cultures.

Authors:  E A Gould; N A Ratcliffe; O Basarab; H Smith
Journal:  Br J Exp Pathol       Date:  1972-02

3.  Widespread distribution in human tissues of an antigenic determinant of granulocytes.

Authors:  A J Howie; G Brown; A G Fisher; M Khan
Journal:  J Clin Pathol       Date:  1984-05       Impact factor: 3.411

4.  Distribution of viral antigen with the lower respiratory tract of ferrets infected with a virulent influenza virus: production and release of virus from corresponding organ cultures.

Authors:  R H Husseini; C Sweet; R A Bird; M H Collie; H Smith
Journal:  J Gen Virol       Date:  1983-03       Impact factor: 3.891

5.  Influenza virus replication in human alveolar macrophages.

Authors:  B C Rodgers; C A Mims
Journal:  J Med Virol       Date:  1982       Impact factor: 2.327

6.  Persistence of influenza as an immunogen in pulmonary antigen-presenting cells.

Authors:  M F Lipscomb; D Yeakel-Houlihan; C R Lyons; R R Gleason; J Stein-Streilein
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

7.  Role of macrophage activation and interferon in the resistance of alveolar macrophages from infected mice to influenza virus.

Authors:  B C Rodgers; C A Mims
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

8.  Differential distribution of virus and histological damage in the lower respiratory tract of ferrets infected with influenza viruses of differing virulence.

Authors:  C Sweet; J C Macartney; R A Bird; D Cavanagh; M H Collie; R H Husseini; H Smith
Journal:  J Gen Virol       Date:  1981-05       Impact factor: 3.891

9.  The localization of influenza virus in the respiratory tract of ferrets: susceptible nasal mucosa cells produce and release more virus than susceptible lung cells.

Authors:  D Cavanagh; F Mitkis; C Sweet; M H Collie; H Smith
Journal:  J Gen Virol       Date:  1979-08       Impact factor: 3.891

10.  Interaction of influenza virus with mouse macrophages.

Authors:  B Rodgers; C A Mims
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

  10 in total
  3 in total

1.  Cytokine release from human peripheral blood leucocytes incubated with endotoxin with and without prior infection with influenza virus: relevance to the sudden infant death syndrome.

Authors:  J B Lundemose; H Smith; C Sweet
Journal:  Int J Exp Pathol       Date:  1993-06       Impact factor: 1.925

2.  Innate immunity to influenza virus: implications for future therapy.

Authors:  Mitchell R White; Mona Doss; Patrick Boland; Tesfaldet Tecle; Kevan L Hartshorn
Journal:  Expert Rev Clin Immunol       Date:  2008-07-01       Impact factor: 4.473

3.  Differentiating severe and non-severe lower respiratory tract illness in patients hospitalized with influenza: Development of the Influenza Disease Evaluation and Assessment of Severity (IDEAS) scale.

Authors:  Eric J Chow; Mark W Tenforde; Melissa A Rolfes; Benjamin Lee; Shreya Chodisetty; Julio A Ramirez; Alicia M Fry; Manish M Patel
Journal:  PLoS One       Date:  2021-10-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.